Evidence map›Paper›PMID 29334910›Full record

ArticleBMC cancer2018

Treatment selection of early stage non-small cell lung cancer: the role of the patient in clinical decision making.

S Mokhles, J J M E Nuyttens, M de Mol, J G J V Aerts, A P W M Maat, Ö Birim, A J J C Bogers, J J M Takkenberg

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
10.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. In their words: Experience of decision-making in adolescents with cancer - a qualitative meta-synthesis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  7. Article
  8. Article
  9. Unmet non-medical needs of cancer patients in Poland: a quantitative and qualitative study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Clinician perspectives on clinical decision support systems in lung cancer: Implications for shared decision-making.Health expectations : an international journal of public participation in health care and health policy · 2022
    Article
  16. Diagnostic timelines and self-reported symptoms of patients with lung and gastrointestinal cancers undergoing radiation therapy. Retrospective case control study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

S MokhlesDepartment of Cardio-thoracic Surgery, Erasmus-MC, Room Bd-577, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. s.mokhles@erasmusmc.nl.
J J M E NuyttensDepartment of Radiation Oncology, Erasmus-MC-Cancer Institute, Rotterdam, The Netherlands.
M de MolDepartment of Pulmonary Disease, Amphia Hospital, Breda, The Netherlands.
J G J V AertsDepartment of Pulmonary Disease, Erasmus-MC, Rotterdam, The Netherlands.
A P W M MaatDepartment of Cardio-thoracic Surgery, Erasmus-MC, Room Bd-577, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.
Ö BirimDepartment of Cardio-thoracic Surgery, Erasmus-MC, Room Bd-577, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.
A J J C BogersDepartment of Cardio-thoracic Surgery, Erasmus-MC, Room Bd-577, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.
J J M TakkenbergDepartment of Cardio-thoracic Surgery, Erasmus-MC, Room Bd-577, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.
Erasmus University Rotterdam · NLAmphia Ziekenhuis · NLErasmus MC · NLErasmus MC Cancer Institute · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe objective of this study is to investigate the role and experience of early stage non-small cell lung cancer (NSCLC) patient in decision making process concerning treatment selection in the current clinical practice.

methodsStage I-II NSCLC patients (surgery 55 patients, SBRT 29 patients, median age 68) were included in this prospective study and completed a questionnaire that explored: (1) perceived patient knowledge of the advantages and disadvantages of the treatment options, (2) experience with current clinical decision making, and (3) the information that the patient reported to have received from their treating physician. This was assessed by multiple-choice, 1-5 Likert Scale, and open questions. The Decisional Conflict Scale was used to assess the decisional conflict. Health related quality of life (HRQoL) was measured with SF-36 questionnaire.

resultsIn 19% of patients, there was self-reported perceived lack of knowledge about the advantages and disadvantages of the treatment options. Seventy-four percent of patients felt that they were sufficiently involved in decision-making by their physician, and 81% found it important to be involved in decision making. Forty percent experienced decisional conflict, and one-in-five patients to such an extent that it made them feel unsure about the decision. Subscores with regard to feeling uninformed and on uncertainty, contributed the most to decisional conflict, as 36% felt uninformed and 17% of patients were not satisfied with their decision. HRQoL was not influenced by patient experience with decision-making or patient preferences for shared decision making.

conclusionsDutch early-stage NSCLC patients find it important to be involved in treatment decision making. Yet a substantial proportion experiences decisional conflict and feels uninformed. Better patient information and/or involvement in treatment-decision-making is needed in order to improve patient knowledge and hopefully reduce decisional conflict.

Indexed as

Clinical Decision-MakingAgedAged, 80 and overCarcinoma, Non-Small-Cell LungDecision MakingFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedNeoplasm StagingPatient ParticipationPhysician-Patient RelationsProspective StudiesQuality of LifeSurveys and QuestionnairesCancer patientsDecision-making preferencesRadiation oncologyShared decision-makingSurgery

Identifiers

PMID29334910
PMCPMC5769349
OpenAlexW2783606501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.